Skip to content
10-Q

Quarterly Report

Acurx Pharmaceuticals, Inc. ACXP

0001558370-25-011045

← back to feed
Filed
Aug 11, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 11, 2025 1.58M sh
Shares Diluted Q2 2025 · Jun 30, 2025 1.19M sh
Shares Diluted Q2 2025 · Jun 30, 2025 1.1M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 791.23K sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 783.87K sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$3.72M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$5.94M
Stockholders Equity Q2 2025 · Jun 30, 2025 $3.57M
Stockholders Equity Q2 2025 · Mar 31, 2025 $2.31M
Stockholders Equity Q2 2025 · Dec 31, 2024 $615.12K
Stockholders Equity Q2 2025 · Jun 30, 2024 $3.43M
Stockholders Equity Q2 2025 · Mar 31, 2024 $6M
Stockholders Equity Q2 2025 · Dec 31, 2023 $4.67M
Current Liabilities Q2 2025 · Jun 30, 2025 $2.59M
Current Liabilities Q2 2025 · Dec 31, 2024 $3.24M
Total Liabilities Q2 2025 · Jun 30, 2025 $2.59M
Total Liabilities Q2 2025 · Dec 31, 2024 $3.24M
Current Assets Q2 2025 · Jun 30, 2025 $6.16M
Current Assets Q2 2025 · Dec 31, 2024 $3.86M
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.89
Eps Diluted Q2 2025 · Jun 30, 2025 −$4.01
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$5.21
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$10.84
Eps Basic Q2 2025 · Jun 30, 2025 −$1.89
Eps Basic Q2 2025 · Jun 30, 2025 −$4.01
Eps Basic restated Q2 2025 · Jun 30, 2024 −$5.21
Eps Basic restated Q2 2025 · Jun 30, 2024 −$10.84
Rd Expense Q2 2025 · Jun 30, 2025 $524.21K
Rd Expense Q2 2025 · Jun 30, 2025 $1.12M
Rd Expense Q2 2025 · Jun 30, 2024 $1.83M
Rd Expense Q2 2025 · Jun 30, 2024 $3.38M
Net Income Q2 2025 · Jun 30, 2025 −$2.25M
Net Income Q2 2025 · Jun 30, 2025 −$4.4M
Net Income Q2 2025 · Mar 31, 2025 −$2.15M
Net Income Q2 2025 · Jun 30, 2024 −$4.12M
Net Income Q2 2025 · Jun 30, 2024 −$8.5M
Net Income Q2 2025 · Mar 31, 2024 −$4.38M
Operating Income Q2 2025 · Jun 30, 2025 −$2.27M
Operating Income Q2 2025 · Jun 30, 2025 −$4.45M
Operating Income Q2 2025 · Jun 30, 2024 −$4.12M
Operating Income Q2 2025 · Jun 30, 2024 −$8.5M